HOUSTON, May 15 /PRNewswire-USNewswire/ -- The American Association of Clinical Endocrinologists and the American College of Endocrinology (AACE and ACE) today released a Position Statement on Physician/Industry Relationships. The position is a strong statement in support of continuing the beneficial and ethical collaboration between physicians and industry.
The statement, shown below in its entirety, was released at the AACE 18th Annual Meeting and Clinical Congress in Houston.
"The American Association of Clinical Endocrinologists and The American College of Endocrinology (AACE and ACE) believe that interaction between physicians and industry has contributed to safe, effective, and value- oriented health care. AACE and ACE affirm that relationships between physicians and industry have been overwhelmingly consistent with ethical standards and responsive to the needs of patients.
There is no inherent conflict of interest in the working relationship of physicians with industry and government. Rather, there is a commonality of interest that is healthy, desirable, and beneficial. The collaborative and constructive relationship among physicians, government, and industry has resulted in many medical advancements and improved health outcomes.
Since their inception, AACE and ACE have formulated policies and procedures to guide the conduct of the organizations and their members in cooperative interactions with industry and with government. These policies are continually being updated to reflect the changing practice and health care environment. AACE and ACE are committed to preserving relationships, including those with industry and with government, that contribute to the fulfillment of their basic mission: to enhance physicians' ability to provide the highest quality of medical care for patients with endocrine disorders."
-AACE and ACE Position Statement on Physician/Industry Relationships
May 15, 2009
"Physician and industry collaboration has advanced the treatment of major illnesses such as diabetes, heart disease, osteoporosis, high cholesterol and hypertension," said Daniel Duick, MD, FACP FACE, and President of the AACE. "The overwhelming majority of physicians, in all fields of healthcare, evaluate and apply advances that are deemed effective, safe and result in best clinical practice outcomes; and, they do so with their patients in mind, and not for pharmaceutical perks."
The Position Statement will be published in the May/June issue of Endocrine Practice, the Journal of the American Association of Clinical Endocrinologists.
To view a copy of the AACE and ACE policies and procedures regarding the disclosure of conflicts of interest, please click here.
For more information on the AACE 18th Annual Meeting and Clinical Congress, click here.
A short, one page bio and high resolution photo of AACE President Daniel Duick, MD, FACP, FACE, are available here.
AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.
|SOURCE American Association of Clinical Endocrinologists|
Copyright©2009 PR Newswire.
All rights reserved